Health Management Associates Comments on Recent Glenview Capital Management Filings
NAPLES, Fla.--(BUSINESS WIRE)-- Health Management Associates, Inc. (NYSE:HMA) commented today on preliminary materials filed by Glenview Capital Management, LLC, with the Securities and Exchange Commission this morning related to the composition of HMAs Board of Directors.
HMAs Board of Directors recently engaged Morgan Stanley to assist with its ongoing consideration of strategic alternatives and opportunities available to HMA.
HMAs Board of Directors is reviewing Glenviews filings and will respond in due course.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as expects, estimates, projects, anticipates, believes, intends, plans, may, pending, continues, should, could and other similar words. All statements addressing operating performance, events or developments that Health Management Associates, Inc. expects or anticipates will occur in the future, including but not limited to projections of revenue, provisions for doubtful accounts, income or loss, capital expenditures, debt structure, principal payments on debt, capital structure, the amount and timing of funds under the meaningful use measurement standard of various Healthcare Information Technology incentive programs, other financial items and operating statistics, statements regarding our plans and objectives for future operations, the impact of changes in observation stays, our ability to achieve process efficiencies, factors we believe may have an impact on our deductibles and co-pays, acquisitions, acquisition financing, divestitures, joint ventures, market service development and other transactions, statements of future economic performance, statements regarding our legal proceedings and other loss contingencies (including, but not limited to, the timing and estimated costs of such matters), statements regarding market risk exposures, statements regarding the effects and/or interpretations of recently enacted or future health care laws and regulations, statements regarding the potential impact of health care exchanges, statements of the beliefs or assumptions underlying or relating to any of the foregoing statements, and statements that are other than statements of historical fact, are considered to be forward-looking statements.
Because they are forward-looking, such statements should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties are more fully described in Health Management Associates, Inc.s most recent Annual Report on Form 10-K, including under the heading entitled Risk Factors. Should one or more of these risks or uncertainties materialize, or should any of Health Management Associates, Inc.s underlying beliefs or assumptions prove incorrect, actual results could vary materially from those currently anticipated. In addition, undue reliance should not be placed on Health Management Associates, Inc.s forward-looking statements. Except as required by law, Health Management Associates, Inc. disclaims any obligation to update its risk factors or to publicly announce updates to the forward-looking statements contained in this press release to reflect new information, future events or other developments.
Additional Information and Where to Find It
HMA and its directors and executive officers may be deemed to be participants in the solicitation of consent revocations from HMA stockholders in connection with the consent solicitation conducted by Glenview Capital Management and certain of its affiliates. Information about HMA officers and directors and their ownership of HMA common shares is set forth in the proxy statement for HMAs 2013 Annual Meeting of Stockholders, which was filed with the Securities and Exchange Commission (the SEC) on April 4, 2013. Information about HMA officers and directors is set forth in HMAs Annual Report on Form 10-K for the year ended December 31, 2012, which was filed with the SEC (SCUR) on February 27, 2013. Investors and security holders may obtain more detailed information regarding the direct and indirect interests of the participants in the solicitation of consent revocations in connection with the consent solicitation conducted by Glenview Capital Management and certain of its affiliates by reading the preliminary and definitive consent revocation statement statements regarding the transaction, which will be filed by HMA with the SEC.
In connection with the consent solicitation, HMA will file a preliminary consent revocation statement with the SEC in response to the consent solicitation. SHAREHOLDERS ARE URGED TO READ THE CONSENT REVOCATION STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT HMA WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders may obtain free copies of these documents (when they are available) and other documents filed with the SEC at the SECs web site at www.sec.gov. In addition, the documents filed by HMA with the SEC may be obtained free of charge by contacting HMA at HMA, Attn: Investor Relations, (239) 598-3131. HMAs filings with the SEC are also available on its website at ir.hma.com.
Health Management Associates, Inc.
MaryAnn M. Hodge, 239-598-3131
Vice President, Marketing & Communication
Source: Health Management Associates, Inc.Copyright Business Wire 2013